#USA #New York #Kidney Health #National Kidney Foundation #Dr. Hurlbert

Dr. Marc Hurlbert Begins Tenure as Chief Executive Officer of the National Kidney Foundation

On July 1, 2026, Dr. Marc Hurlbert officially took on the responsibilities of Chief Executive Officer at the National Kidney Foundation (NKF). This transition is pivotal as the NKF embarks on the next chapter of its over 75-year history dedicated to enhancing kidney health and saving lives.

Dr. Hurlbert expressed immense pride in leading an organization celebrated for its significant contributions to kidney health advocacy. He stated, "It is an honor to join an organization with such a remarkable legacy of advancing kidney health on behalf of patients and families." His initial focus will be on engaging with a variety of stakeholders—patients, families, staff, volunteers, and partners. Through these discussions, he aims to gather insights that will shape his leadership approach and set priorities moving forward.

Dr. Hurlbert's impressive career spans more than 25 years, primarily spent in roles that promote research, patient advocacy, public health initiatives, and health equity in the healthcare sector. His deep commitment to improving the quality of life for patients stems from both professional and personal experiences; notably, he has been a caregiver for a family member suffering from chronic kidney disease.

During his career, he has managed to secure over $750 million in funding through more than 4,000 grants, benefiting numerous hospitals, medical centers, and community organizations involved in tackling critical public health challenges. His reputation in the field is bolstered by his ability to foster collaboration across various organizations, including academia, government agencies, and private sector stakeholders in biotechnology and pharmaceuticals, all aimed at enhancing health outcomes.

Reflecting on the current state of kidney health, Dr. Hurlbert remarked, "This is a defining moment for NKF. Science is advancing at remarkable speed, and patients are urging us to take the lead in educating both the public and healthcare providers about the kidney disease public health crisis, while also addressing the urgent need for more organ transplants and preventive measures to halt the progression of kidney dysfunction. NKF is uniquely positioned to lead this next era of impact."

In the upcoming weeks, Dr. Hurlbert will immerse himself into learning about NKF's operations by interacting closely with staff, volunteers, and healthcare professionals. These interactions are crucial for identifying ways to refine NKF's initiatives in advocacy, research, and education.

Kevin Longino, the outgoing CEO who has successfully led NKF since 2015, expressed his confidence in Dr. Hurlbert’s capability. "Having worked closely with Marc throughout this transition, I know his passion for improving patient outcomes and driving systems change will significantly benefit NKF. I’m excited to support him in this transformative period."

For over 75 years, the NKF has been a trailblazer in shaping the future of kidney care through advocacy, public education, and innovative research. The foundation has played a noteworthy role in developing essential guidelines for kidney disease treatment and pushing for equitable health solutions.

Kidney disease remains a significant public health challenge in the U.S., impacting one in seven adults. Alarmingly, a staggering 90% of those affected are unaware of their condition. Factors contributing to kidney disease include diabetes, hypertension, and heart disease, with heightened risks observed in certain demographic groups, including Black or Hispanic individuals.

As the NKF enters this new chapter under Dr. Hurlbert’s leadership, there is a renewed hope for tackling the escalating public health challenge posed by kidney disease and enhancing the trajectory of care for those affected.

For further insights into the NKF and to stay informed about Dr. Hurlbert's efforts, please visit kidney.org.